tiprankstipranks
Advertisement
Advertisement

FR:IPH Stock Latest News

Innate Pharma Schedules May 13 Webcast on First-Quarter 2026 Business Progress
Company AnnouncementsInnate Pharma Schedules May 13 Webcast on First-Quarter 2026 Business Progress
16h ago
6K
Innate Pharma Plans Investor Meetings at D. Boral Capital Global Conference in New York
PremiumCompany Announcements
Innate Pharma Plans Investor Meetings at D. Boral Capital Global Conference in New York
14d ago
6K
Innate Pharma Showcases Encouraging Phase 2 IPH5201 Lung Cancer Data at AACR 2026
PremiumCompany Announcements
Innate Pharma Showcases Encouraging Phase 2 IPH5201 Lung Cancer Data at AACR 2026
19d ago
6K
Innate Pharma Sets May 21, 2026 Date for Annual General Meeting in Marseille
PremiumCompany Announcements
Innate Pharma Sets May 21, 2026 Date for Annual General Meeting in Marseille
24d ago
6K
Innate Pharma Reports Share Capital and Voting Rights as of April 9, 2026
PremiumCompany Announcements
Innate Pharma Reports Share Capital and Voting Rights as of April 9, 2026
24d ago
6K
Innate Pharma to Showcase Oncology Pipeline at AACR 2026 Partnering Event
PremiumCompany AnnouncementsInnate Pharma to Showcase Oncology Pipeline at AACR 2026 Partnering Event
29d ago
6K
Innate Pharma: Underappreciated Topo‑I ADC Pipeline and Differentiated IPH4502 Support Buy Rating
Premium
Ratings
Innate Pharma: Underappreciated Topo‑I ADC Pipeline and Differentiated IPH4502 Support Buy Rating
29d ago
IPHA
Innate Pharma Balances Pipeline Progress With Cash Strain
Premium
Company Announcements
Innate Pharma Balances Pipeline Progress With Cash Strain
1M ago
Innate Pharma to Engage Investors at Kempen Life Sciences Conference in Amsterdam
PremiumCompany Announcements
Innate Pharma to Engage Investors at Kempen Life Sciences Conference in Amsterdam
1M ago
6K
Innate Pharma Files 2025 Annual Reports with AMF and U.S. SEC
PremiumCompany Announcements
Innate Pharma Files 2025 Annual Reports with AMF and U.S. SEC
1M ago
6K
Innate Pharma Posts 2025 Results, Flags H2 2026 CTCL Phase 3 Start Amid Cash Runway to Q3
PremiumCompany Announcements
Innate Pharma Posts 2025 Results, Flags H2 2026 CTCL Phase 3 Start Amid Cash Runway to Q3
1M ago
6K
Innate Pharma Sets March 26 Webcast to Present Full-Year 2025 Results
PremiumCompany Announcements
Innate Pharma Sets March 26 Webcast to Present Full-Year 2025 Results
2M ago
6K
Innate Pharma assumed with a Buy at BTIG
PremiumThe FlyInnate Pharma assumed with a Buy at BTIG
2M ago
IPHA
Innate Pharma: Diversified Oncology Pipeline and AstraZeneca Partnership Create Compelling Upside Ahead of 2026 Inflection Points
Premium
Ratings
Innate Pharma: Diversified Oncology Pipeline and AstraZeneca Partnership Create Compelling Upside Ahead of 2026 Inflection Points
2M ago
IPHA
Innate Pharma to Spotlight Cancer Immunotherapy Pipeline at Leerink Global Healthcare Conference
Premium
Company Announcements
Innate Pharma to Spotlight Cancer Immunotherapy Pipeline at Leerink Global Healthcare Conference
3M ago
6K
Innate Pharma Updates Share Capital and Voting Rights as of December 31, 2025
PremiumCompany Announcements
Innate Pharma Updates Share Capital and Voting Rights as of December 31, 2025
4M ago
6K
Innate Pharma Updates Share Capital and Voting Rights as of December 18, 2025
PremiumCompany Announcements
Innate Pharma Updates Share Capital and Voting Rights as of December 18, 2025
5M ago
6K
Innate Pharma Announces 2026 Financial Calendar
PremiumCompany Announcements
Innate Pharma Announces 2026 Financial Calendar
5M ago
6K
Innate Pharma Releases Share and Voting Rights Update as of November 27, 2025
PremiumCompany Announcements
Innate Pharma Releases Share and Voting Rights Update as of November 27, 2025
5M ago
6K
Innate Pharma Presents at Jefferies Global Healthcare Conference 2025
PremiumCompany AnnouncementsInnate Pharma Presents at Jefferies Global Healthcare Conference 2025
6M ago
6K
Innate Pharma’s Q3 2025 Update: FDA Clears Phase 3 Trial for Lacutamab
Premium
Company Announcements
Innate Pharma’s Q3 2025 Update: FDA Clears Phase 3 Trial for Lacutamab
6M ago
6K
Innate Pharma Receives FDA Clearance for Phase 3 Lacutamab Trial
Premium
Company Announcements
Innate Pharma Receives FDA Clearance for Phase 3 Lacutamab Trial
6M ago
6K

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >